Quick Takeaways
- Genetel Bioventures Ltd filed SCHEDULE 13G/A for Prenetics Global Ltd Class A Ordinary Shares, par value $0.0015 per share (PRE).
- Disclosed ownership: 3.3%.
- Date of event: 31 Mar 2026.
Genetel Bioventures Ltd - 31 Mar 2026 SCHEDULE 13G/A Report for Prenetics Global Ltd Class A Ordinary Shares, par value $0.0015 per share (PRE)
- Filing Manager
- Genetel Bioventures Ltd
- Reporting Manager
- Genetel Bioventures Ltd
- Symbol
- PRE
- Shares outstanding
- 14,813,848 shares
- Disclosed Ownership
- 488,857 shares
- Ownership
- 3.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 22 Apr 2026, 11:53:50 UTC
- Date of event
- 31 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Genetel Bioventures Ltd disclosed 3.3% ownership in Prenetics Global Ltd Class A Ordinary Shares, par value $0.0015 per share (PRE) on 31 Mar 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 22 Apr 2026, 11:53.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Genetel Bioventures Ltd | 3.3% | 488,857 | 488,857 | 0 | /s/ George William Hunter Cautherley | By: Genetel Bioventures Ltd., By: George William Hunter Cautherley, Director | |
| Michael Yang Mengsu | 3.3% | 488,857 | 488,857 | 0 | /s/ Michael Yang Mengsu | Michael Yang Mengsu, Individually |